株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

血液透析・腹膜透析の世界市場 〜2020年:製品・方式・エンドユーザー別の将来予測

Hemodialysis & Peritoneal Dialysis Market Products (Machine, Dialyzer, Bloodlines, Concentrates, Catheters, Transfer Sets, Water Treatment Systems, & Services), Modality (Nocturnal, APD, & CAPD), End-users (In-center & Home) - Global Forecast to 2020

発行 MarketsandMarkets 商品コード 289914
出版日 ページ情報 英文 265 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
血液透析・腹膜透析の世界市場 〜2020年:製品・方式・エンドユーザー別の将来予測 Hemodialysis & Peritoneal Dialysis Market Products (Machine, Dialyzer, Bloodlines, Concentrates, Catheters, Transfer Sets, Water Treatment Systems, & Services), Modality (Nocturnal, APD, & CAPD), End-users (In-center & Home) - Global Forecast to 2020
出版日: 2015年11月10日 ページ情報: 英文 265 Pages
概要

世界の人工透析市場は今後、6.2%の年平均成長率 (CAGR) で成長し、2020年には938億3000万米ドルの規模に達する、と推計されています。先進国市場では成熟化・低成長率となるものの、新興国市場の急成長や、末期腎疾患 (ESRD)・糖尿病・高血圧などの患者数の増加、人口高齢化といった要素が、市場成長の促進要因になる、と考えられています。一方で、医療費償還額の制限や価格引き下げ圧力など、使い捨て用品の再利用などが、今後の市場成長の妨げとなる可能性があります。市場の86.8%を血液透析が占める一方、腹膜透析の今後の年平均成長率 (CAGR) は7.8%と、血液透析 (同6.0%) よりも高くなっています。

当レポートでは、世界の人工透析 (血液透析・腹膜透析) 製品・サービス市場について分析し、市場の基本構造や最新動向、主な市場促進・阻害要因、市場動向と今後の見通し (過去2年間・今後6年間分)、製品別・透析方式別・エンドユーザー別・地域別の詳細動向、市場競争・資本取引の状態、主要企業のプロファイルなどを調査・考察しております。

第1章 イントロダクション

第2章 分析手法

第3章 エグゼクティブ・サマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場の内訳
  • 市場のダイナミクス
    • 促進要因
      • 末期腎不全 (ESRD) 患者数の増加
      • 糖尿病・高血圧患者の増加
      • 高齢者人口の増大
      • 腎移植より透析処置を選択する患者の増加
      • 技術の進歩と新製品の上市
      • ESRD治療のための巨額の医療費支出
    • 抑制要因
      • 透析に関するリスク・合併症
      • 発展途上国での透析向け医療費償還の制約
      • 北米での透析向け医療費償還額の削減
      • 新製品認証時の厳格な規制
    • 市場機会
      • 新興国市場での巨大な成長機会
      • 使いやすく低コストな製品の進化
      • 透析センターの増加
      • 在宅血液透析の処置件数の増加
    • 課題
      • 透析に対する腎移植の利点 (低コスト、高い患者生存率)
      • 透析治療のコストの高さ

第6章 競争情報分析

  • ポーターのファイブフォース分析
  • 競争密度:透析製品市場 (Baxter、Fresenius、B. Braunの場合)
  • 透析製品・サービス市場:成長戦略の経験的評価 (有機的/無機的成長)

第7章 産業分析

  • イントロダクション
  • 産業動向
    • ウェアラブル/小型透析装置:新たな時代の始まり
    • 透析サービス市場の再編
    • 透析製品・サービス企業間の提携の増加
    • 未公開株取引 (プライベートエクイティ) 活動の活発化・継続化
    • 民間の透析サービス業者の台頭
  • 医療費償還のシナリオ (地域別)
  • 規制環境 (地域別)

第8章 透析の処置件数:方式別

  • イントロダクション
  • 血液透析 (HD) の処置件数
  • 腹膜透析 (PD) の処置件数
  • 血液透析 vs. 腹膜透析

第9章 世界の血液透析市場

  • 製品別・サービス別分析
    • イントロダクション
    • 血液透析製品
      • 血液透析装置 (施設用/在宅用)
      • 血液透析用消耗品・備品
        • ダイアライザー (透析器):素材別、流量別
        • アクセス用製品 (静動脈 (AV) フィステル針、AVグラフト、中央静脈カテーテル (CVC))
        • ブラッドライン
        • 血液透析用濃縮物/透析液
        • その他
    • 血液透析サービス市場
      • 施設内血液透析サービス
      • 在宅血液透析サービス
  • 透析方式別の分析
    • 従来型・長期間の血液透析
    • 短時間・日常的な血液透析
    • 夜間血液透析
  • 水処理装置市場:種類別
    • 集中型水殺菌装置市場
      • 化学式殺菌装置市場
      • 熱式殺菌装置
      • 付属品
    • 可搬式水殺菌装置市場

第10章 世界の腹膜透析市場

  • 製品別・サービス別分析
    • イントロダクション
    • 腹膜透析製品
      • 腹膜透析用濃縮物/透析液
      • 腹膜透析装置
      • 腹膜透析用カテーテル
      • 腹膜透析トランスファーセット
      • その他
    • 腹膜透析サービス
  • 方式別の分析
    • CAPD (連続携行式腹膜透析)
    • APD (自動腹膜透析)

第11章 世界の透析市場:エンドユーザー別

  • イントロダクション
  • 施設内透析 (病院、独立系透析センター)
  • 在宅透析 (腹膜透析、血液透析)

第12章 世界の透析市場:地域別

  • イントロダクション
    • 北米 (米国、カナダ)
    • 欧州 (ドイツ、フランス、英国など)
    • アジア太平洋地域 (日本、中国、インドなど)
    • その他の地域 (ラテンアメリカ、中東、アフリカ)

第13章 競争環境

  • 概要
  • 市場シェア分析:主要企業別
    • 透析製品市場の主要企業
    • 透析サービス市場の主要企業
    • 血液透析市場の主要企業
    • 腹膜透析市場の主要企業
  • 競争状況と動向
  • 昨今の動向
    • 事業拡張
    • 企業合併・買収 (M&A)
    • 契約・事業提携
    • 新製品の上市・認証
    • その他の戦略

第14章 企業プロファイル (企業概要、財務状況、製品・サービス、主要戦略、近年の動向)

  • イントロダクション
  • FRESENIUS MEDICAL CARE AG & CO. KGAA
  • DAVITA HEALTHCARE PARTNERS INC.
  • BAXTER INTERNATIONAL INC.
  • B. BRAUN MELSUNGEN AG
  • DIAVERUM DEUTSCHLAND GMBH
  • ニプロ
  • 旭化成メディカル (旭化成の子会社)
  • 日機装
  • NXSTAGE MEDICAL, INC.
  • MAR COR PURIFICATION, INC. (A CANTEL MEDICAL COMPANY)

第15章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 2157

The global dialysis market is poised to reach USD 93.83 billion by 2020, growing at a CAGR of 6.2% during the forecast period. Although the global dialysis market is estimated to grow at a lower CAGR in developed countries; however, it is expected to witness high growth in emerging countries such as China, India, and Brazil. Factors such as the rising number of ESRD patients across the globe, increasing prevalence of diabetes and hypertension, growth in aging population, low patient preference towards kidney transplantation, and technological advancements are propelling the growth of the dialysis market. However, factors such as the decrease in Medicare reimbursements, pricing pressures, low awareness about kidney diseases and renal treatment modalities, product recalls, and reuse of hemodialysis consumables are restraining the growth of this market.

In this report, the global dialysis market has been segmented on the basis of category (hemodialysis and peritoneal dialysis) and end-users (in-center dialysis and home dialysis). Based on modality, the hemodialysis segment is further categorized into, conventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis; whereas the peritoneal dialysis segment comprises continuous ambulatory peritoneal dialysis (CAPD) and ambulatory peritoneal dialysis (APD).

The hemodialysis market holds the largest share of 86.8% of the global dialysis market in 2015 and is poised to grow at a CAGR of 6.0% in the forecast period. Factors such as the huge acceptance of hemodialysis therapy over peritoneal dialysis among CKD and ESRD patients, increasing number of ESRD patients, growth in the number of dialysis centers, and government initiatives are stimulating the growth of the hemodialysis market. However, the peritoneal dialysis market is estimated to grow at a high CAGR of 7.8% from 2015 to 2020.

Geographically, North America commands the largest share of 36.9% the global dialysis market in 2015, followed by Asia-Pacific. A number of factors such as the high number of dialysis centers, rapid adoption rate of advanced technologies, increasing prevalence of diabetes and hypertension, structured reimbursement system, and availability of skilled nephrologists and well equipped dialysis centers/hospitals are driving the growth of the dialysis market in North America; however, reduction in the reimbursement rate and low utilization of home dialysis are hampering the growth of the dialysis market in this region. The Asia-Pacific region is poised to grow at the highest CAGR of 9.7% of the global dialysis market in the next five years. Factors such as the presence of a large patient population base, increasing number of private and public owned dialysis centers, improving reimbursement and insurance scenario, rising focus of global players, and increasing government initiatives are propelling the growth of the dialysis market in the Asia-Pacific region.

The global dialysis market is highly competitive, with a large number of players (including dialysis products market players and dialysis services market players). As of 2014, the global dialysis products market was dominated by Fresenius Medical Care AG & Co. KGaA (Germany) and Baxter International, Inc. (U.S.), which together accounted for ~63% of the market; whereas in the global dialysis services market, Fresenius Medical Care AG & Co. KGaA (Germany), DaVita Healthcare Partners, Inc. (U.S.), and Diaverum Deutschland GmbH (Germany) were the top three market players. Partnerships/agreements/collaborations/joint-ventures, and acquisitions are the major strategies adopted by most of the market players, to achieve growth in the dialysis market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis - industry analysis (porter's five force model), market share analysis of top players, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high growth segments of the dialysis market, high growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities. The above mentioned market research data, current market size, and forecast of future trends will help existing players and new entrants to make the necessary decisions regarding the product offerings, geographic focus, change in strategic approach, R&D investment for innovation in products and technologies, and levels of output in order to remain successful.

Firms purchasing the report could use any one or combination of the below mentioned five strategies (Market Penetration, Product Development/Innovation, Market Development, Market Diversification, and Competitive Assessment) for reaping market share.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on dialysis products and services offered by the top 10 players in the global dialysis market. The report analyzes the dialysis market by product, service, modality, and region
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various dialysis products and services across key geographic regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global dialysis market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and recent developments of the leading players in the global dialysis market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key data from primary sources
      • 2.2.2.2. Key industry insights
        • 2.2.2.2.1. Supply side
        • 2.2.2.2.2. Demand side
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
    • 2.3.1. ESTIMATION OF DIALYSIS PROCEDURAL VOLUME
    • 2.3.2. RESEARCH METHODOLOGY: TOP-DOWN APPROACH {FOR MARKET SIZE ESTIMATION OF HD AND PD DISPOSABLES(BLOODLINE SETS, DIALYZERS, CATHETERS, TRANSFER SETS, AND CONCENTRATES/DIALYSATES)}
    • 2.3.3. RESEARCH METHODOLOGY: TOP-DOWN APPROACH(FOR MARKET-SIZE ESTIMATION OF HD/PD MACHINES)
    • 2.3.4. RESEARCH METHODOLOGY: BOTTOM-UP APPROACH(FOR HD AND PD DIALYSIS PRODUCTS MARKET)
    • 2.3.5. RESEARCH METHODOLOGY: BOTTOM-UP APPROACH(FOR HD AND PD DIALYSIS SERVICES MARKET)
  • 2.4. RESEARCH DESIGN
  • 2.5. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.6. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. DIALYSIS MARKET OVERVIEW
  • 4.2. REGIONAL ANALYSIS: DIALYSIS MARKET, BY MODALITY, 2015 VS. 2020(USD BILLION)
  • 4.3. REGIONAL ANALYSIS: DIALYSIS MARKET, BY END USER, 2013-2020(USD BILLION)
  • 4.4. REGIONAL ANALYSIS: DIALYSIS MARKET, BY PRODUCTS & SERVICES, 2015 VS. 2020(USD BILLION)
  • 4.5. REGIONAL ANALYSIS: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2015 VS. 2020(USD BILLION)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Increasing number of ESRD patients
      • 5.3.1.2. Growing number of patients suffering from diabetes and hypertension
      • 5.3.1.3. Rise in aging population
      • 5.3.1.4. Rising adoption of dialysis procedures over renal transplants
        • 5.3.1.4.1. Low preference of patients for kidney transplantation
      • 5.3.1.5. Technological advancements and new product launches
        • 5.3.1.5.1. Rising R&D expenditure for the development of new dialysis products
      • 5.3.1.6. Substantial healthcare expenditure on the treatment of end-stage renal disease
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Risks and complications associated with dialysis
        • 5.3.2.1.1. High risk and complications related to vascular access
      • 5.3.2.2. Product recalls
      • 5.3.2.3. Limited reimbursements for dialysis in developing countries
      • 5.3.2.4. Reimbursement cuts for dialysis in North America
      • 5.3.2.5. Stringent regulatory policies for the approval of new dialysis products
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Emerging markets offer lucrative growth opportunities
      • 5.3.3.2. Evolution of user-friendly and low-cost dialysis products
      • 5.3.3.3. Increasing number of dialysis centers
      • 5.3.3.4. Growing adoption of home hemodialysis treatment
    • 5.3.4. CHALLENGES
      • 5.3.4.1. Benefits of renal transplantation versus dialysis
        • 5.3.4.1.1. Low cost
        • 5.3.4.1.2. Better patient survival rate
      • 5.3.4.2. Sustainability of players in the highly competitive market
      • 5.3.4.3. High cost of dialysis treatment

6. COMPETITIVE INTELLIGENCE ANALYSIS

  • 6.1. PORTER'S FIVE FORCES ANALYSIS
    • 6.1.1. SEGMENT RIVALRY
    • 6.1.2. THREAT OF SUBSTITUTES
    • 6.1.3. THREAT OF NEW ENTRANTS
    • 6.1.4. SUPPLIER'S BARGAINING POWER
    • 6.1.5. BUYER'S BARGAINING POWER
  • 6.2. COMPETITIVE INTENSITY: DIALYSIS PRODUCTS MARKET
    • 6.2.1. EVALUATION PARAMETERS AND SCORES
    • 6.2.2. SCORING METHODOLOGY
    • 6.2.3. COMPETITIVE INTENSITY SCORE, BY COMPANY
      • 6.2.3.1. Baxter
      • 6.2.3.2. Fresenius
      • 6.2.3.3. B. Braun
    • 6.2.4. COMPETITIVE INTENSITY - MAPPING OF BAXTER, B.BRAUN, AND FRESENIUS
  • 6.3. DIALYSIS PRODUCTS AND SERVICES MARKET: EMPIRICAL ASSESSMENT OF GROWTH STRATEGIES
      • 6.3.1.1. Path Towards Strategic Development - Organic and Inorganic Growth Strategies
      • 6.3.1.2. Dialysis Products Market
        • 6.3.1.2.1. Organic Growth Strategies
        • 6.3.1.2.2. Inorganic Growth Strategies
      • 6.3.1.3. Dialysis Services Market
        • 6.3.1.3.1. Organic Growth Strategies
        • 6.3.1.3.2. Inorganic Growth Strategies

7. INDUSTRY INSIGHTS

  • 7.1. INTRODUCTION
  • 7.2. INDUSTRY TRENDS
    • 7.2.1. WEARABLE AND MINIATURE DIALYSIS MACHINES - A NEW DAWN OF DIALYSIS
    • 7.2.2. CONSOLIDATION OF THE DIALYSIS SERVICES MARKET
    • 7.2.3. ONGOING PARTNERSHIPS AMONG DIALYSIS PRODUCTS AND SERVICES PROVIDERS
    • 7.2.4. CONTINUING ROBUST PRIVATE EQUITY ACTIVITY
    • 7.2.5. INCREASING TREND TOWARDS PRIVATE DIALYSIS PROVIDERS
  • 7.3. REIMBURSEMENT SCENARIO
    • 7.3.1. NORTH AMERICA
    • 7.3.2. EUROPE
      • 7.3.2.1. Germany
      • 7.3.2.2. France
      • 7.3.2.3. Belgium
      • 7.3.2.4. U.K.
      • 7.3.2.5. Netherlands
    • 7.3.3. ASIA-PACIFIC
      • 7.3.3.1. Asian Region(Except Japan)
      • 7.3.3.2. Japan
      • 7.3.3.3. Pacific region
    • 7.3.4. REST OF THE WORLD
      • 7.3.4.1. Latin America
      • 7.3.4.2. Africa
  • 7.4. REGULATORY LANDSCAPE
    • 7.4.1. NORTH AMERICA
      • 7.4.1.1. U.S.
      • 7.4.1.2. Canada
    • 7.4.2. EUROPE
    • 7.4.3. ASIA-PACIFIC
      • 7.4.3.1. India
      • 7.4.3.2. China
      • 7.4.3.3. Japan
      • 7.4.3.4. South Korea
    • 7.4.4. REST OF THE WORLD
      • 7.4.4.1. Latin America
        • 7.4.4.1.1. Brazil
        • 7.4.4.1.2. Argentina
        • 7.4.4.1.3. Mexico
      • 7.4.4.2. Middle East
      • 7.4.4.3. Africa

8. ADOPTION OF DIALYSIS MODALITIES, BY PROCEDURAL VOLUME

  • 8.1. INTRODUCTION
  • 8.2. HEMODIALYSIS(HD) PROCEDURES
  • 8.3. PERITONEAL DIALYSIS(PD) PROCEDURES
  • 8.4. HD VS. PD

9. GLOBAL HEMODIALYSIS MARKET

  • 9.1. HEMODIALYSIS MARKET, BY PRODUCTS & SERVICES
    • 9.1.1. INTRODUCTION
    • 9.1.2. HEMODIALYSIS PRODUCTS
      • 9.1.2.1. Hemodialysis Machines
        • 9.1.2.1.1. Center-use Hemodialysis Machines
        • 9.1.2.1.2. Home-use Hemodialysis Machines
      • 9.1.2.2. Hemodialysis Consumables/Supplies
        • 9.1.2.2.1. Dialyzers
        • 9.1.2.2.2. Dialyzers market, by material type
        • 9.1.2.2.2.1. Cellulose-based dialyzers
        • 9.1.2.2.2.2. Synthetic dialyzers
        • 9.1.2.2.3. Dialyzers market, by flux type
        • 9.1.2.2.3.1. High-flux Dialyzers
        • 9.1.2.2.3.2. Low-flux Dialyzers
        • 9.1.2.2.4. Hemodialysis Access Products
        • 9.1.2.2.4.1. Arteriovenous(AV) Fistula
        • 9.1.2.2.4.2. A-V Graft
        • 9.1.2.2.4.3. Central Venous Catheter(CVC)
        • 9.1.2.2.5. Bloodlines
        • 9.1.2.2.6. Hemodialysis Concentrates/Dialysates
        • 9.1.2.2.7. Other hemodialysis consumables
    • 9.1.3. HEMODIALYSIS SERVICES
      • 9.1.3.1. In-center Hemodialysis Services
      • 9.1.3.2. Home Hemodialysis Services
  • 9.2. HEMODIALYSIS MARKET, BY MODALITY
    • 9.2.1. CONVENTIONAL LONG-TERM HEMODIALYSIS
    • 9.2.2. SHORT DAILY HEMODIALYSIS
    • 9.2.3. NOCTURNAL HEMODIALYSIS
  • 9.3. WATER TREATMENT SYSTEMS MARKET, BY TYPE
    • 9.3.1. CENTRAL WATER DISINFECTION SYSTEMS MARKET
      • 9.3.1.1. Chemical Disinfection Systems Market
      • 9.3.1.2. Heat Disinfection Systems
      • 9.3.1.3. Accessories
    • 9.3.2. PORTABLE WATER DISINFECTION SYSTEMS MARKET
      • 9.3.2.1. Chemical Disinfection Systems
      • 9.3.2.2. Heat Disinfection Systems
      • 9.3.2.3. Accessories

10. GLOBAL PERITONEAL DIALYSIS MARKET

  • 10.1. PERITONEAL DIALYSIS MARKET, BY PRODUCT AND SERVICE
    • 10.1.1. INTRODUCTION
    • 10.1.2. PERITONEAL DIALYSIS PRODUCTS
      • 10.1.2.1. Peritoneal Dialysis Concentrate/Dialysate
      • 10.1.2.2. Peritoneal Dialysis Machines
      • 10.1.2.3. Peritoneal Dialysis Catheters
      • 10.1.2.4. Peritoneal Dialysis Transfer Sets
      • 10.1.2.5. Others
    • 10.1.3. PERITONEAL DIALYSIS SERVICES
  • 10.2. PERITONEAL DIALYSIS MARKET, BY MODALITY
    • 10.2.1. CONTINUOUS AMBULATORY PERITONEAL DIALYSIS(CAPD)
    • 10.2.2. AUTOMATED PERITONEAL DIALYSIS(APD)

11. GLOBAL DIALYSIS MARKET, BY END USER

  • 11.1. INTRODUCTION
  • 11.2. IN-CENTER DIALYSIS
    • 11.2.1. HOSPITAL DIALYSIS
    • 11.2.2. INDEPENDENT DIALYSIS CENTERS
  • 11.3. HOME DIALYSIS
    • 11.3.1. PERITONEAL DIALYSIS
    • 11.3.2. HOME HEMODIALYSIS

12. GLOBAL DIALYSIS MARKET, BY REGION

  • 12.1. INTRODUCTION
    • 12.1.1. NORTH AMERICA
      • 12.1.1.1. Consolidation of markets in North America
      • 12.1.1.2. U.S.
        • 12.1.1.2.1. Bundle reimbursement, a strong incentive for dialysis providers to encourage PD adoption
        • 12.1.1.2.2. Underutilization of home HD in the U.S.
      • 12.1.1.3. Canada
        • 12.1.1.3.1. High government expenditure for not-for-profit hospitals to deliver dialysis care
        • 12.1.1.3.2. Rising focus of provincial hospitals on providing quality care
    • 12.1.2. EUROPE
      • 12.1.2.1. Wide variations in Europe for the adoption of dialysis
      • 12.1.2.2. Germany
        • 12.1.2.2.1. High competition in the German dialysis market
      • 12.1.2.3. France
        • 12.1.2.3.1. Improvement in reimbursement scenario for dialysis in France
      • 12.1.2.4. U.K.
        • 12.1.2.4.1. The U.K., an attractive market for small dialysis players
        • 12.1.2.4.2. Low utilization of home dialysis in the U.K.
      • 12.1.2.5. Rest of Europe
        • 12.1.2.5.1. Huge growth potential in Eastern Europe
    • 12.1.3. ASIA-PACIFIC
      • 12.1.3.1. Dialysis Firms increasingly focusing on Asia-Pacific
      • 12.1.3.2. High cost of treatment and poor reimbursement hindering utilization of dialysis
      • 12.1.3.3. Japan
        • 12.1.3.3.1. Low preference for kidney transplantation driving the adoption of dialysis
        • 12.1.3.3.2. High entry barriers in Japan for foreign players
      • 12.1.3.4. China
        • 12.1.3.4.1. China halts anti-dumping probe into foreign dialysis kit makers
      • 12.1.3.5. India
        • 12.1.3.5.1. Evolving home dialysis treatment in the country
        • 12.1.3.5.2. Poor accessibility of dialysis treatment
        • 12.1.3.5.3. Dearth of indigenous manufacturers for dialysis machines and dialyzers in India
      • 12.1.3.6. Rest of Asia-Pacific(RoAPAC)
        • 12.1.3.6.1. South Korean dialysis market is growing at a high rate
        • 12.1.3.6.2. Underutilization of home dialysis in Australia
        • 12.1.3.6.3. High ESRD prevalence and rising government focus driving the growth of the Taiwanese dialysis market
        • 12.1.3.6.4. Effective promotion of PD in Hong Kong
    • 12.1.4. REST OF THE WORLD
      • 12.1.4.1. Latin America
        • 12.1.4.1.1. High usage of PD in the Latin America
        • 12.1.4.1.2. New amendments open Brazilian dialysis industry to foreign investment
        • 12.1.4.1.3. Mexico shows the highest utilization of PD in the world
      • 12.1.4.2. Middle East
        • 12.1.4.2.1. Rising government funding towards the treatment of dialysis is driving the market in Saudi Arabia
      • 12.1.4.3. Africa

13. COMPETITIVE LANDSCAPE

  • 13.1. OVERVIEW
  • 13.2. MARKET SHARE ANALYSIS, BY KEY PLAYER
    • 13.2.1. KEY PLAYERS IN THE DIALYSIS PRODUCTS MARKET
    • 13.2.2. KEY PLAYERS IN THE DIALYSIS SERVICES MARKET
    • 13.2.3. KEY PLAYERS IN THE HEMODIALYSIS PRODUCTS MARKET
    • 13.2.4. KEY PLAYERS IN THE PERITONEAL DIALYSIS PRODUCTS MARKET
  • 13.3. COMPETITIVE SITUATION AND TRENDS
  • 13.4. RECENT DEVELOPMENTS
    • 13.4.1. EXPANSION
    • 13.4.2. MERGERS & ACQUISITIONS
    • 13.4.3. AGREEMENTS & PARTNERSHIPS
    • 13.4.4. NEW PRODUCT LAUNCHES AND APPROVALS
    • 13.4.5. OTHER STRATEGIES

14. COMPANY PROFILES

  • 14.1. INTRODUCTION
  • 14.2. FRESENIUS MEDICAL CARE AG & CO. KGAA
  • 14.3. DAVITA HEALTHCARE PARTNERS INC.
  • 14.4. BAXTER INTERNATIONAL INC.
  • 14.5. B. BRAUN MELSUNGEN AG
  • 14.6. DIAVERUM DEUTSCHLAND GMBH
  • 14.7. NIPRO CORPORATION
  • 14.8. ASAHI KASEI MEDICAL CO., LTD.(A SUBSIDIARY OF ASAHI KASEI CORPORATION)
  • 14.9. NIKKISO CO., LTD.
  • 14.10. NXSTAGE MEDICAL, INC.
  • 14.11. MAR COR PURIFICATION, INC.(A CANTEL MEDICAL COMPANY)

*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

15. APPENDIX

  • 15.1. INSIGHTS OF INDUSTRY EXPERTS
  • 15.2. DISCUSSION GUIDE
  • 15.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 15.4. AVAILABLE CUSTOMIZATIONS
  • 15.5. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: PROMINENT ACQUISITIONS IN THE DIALYSIS SERVICES INDUSTRY (2012-2015)
  • TABLE 2: GLOBAL HEMODIALYSIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD BILLION)
  • TABLE 3: GLOBAL HEMODIALYSIS PRODUCTS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 4: GLOBAL HEMODIALYSIS PRODUCTS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 5: GLOBAL HEMODIALYSIS MACHINES MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 6: GLOBAL HEMODIALYSIS MACHINES MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 7: CENTER-USE HEMODIALYSIS MACHINES MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 8: GLOBAL HOME-USE HEMODIALYSIS MACHINES MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 9: GLOBAL HEMODIALYSIS CONSUMABLES/SUPPLIES MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 10: GLOBAL HEMODIALYSIS CONSUMABLES/SUPPLIES MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 11: GLOBAL DIALYZERS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 12: GLOBAL DIALYZERS MARKET SIZE, BY MATERIAL TYPE, 2013-2020 (USD BILLION)
  • TABLE 13: GLOBAL CELLULOSE-BASED DIALYZERS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 14: GLOBAL SYNTHETIC DIALYZERS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 15: GLOBAL DIALYZERS MARKET SIZE, BY FLUX TYPE, 2013-2020 (USD BILLION)
  • TABLE 16: HIGH-FLUX DIALYZERS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 17: GLOBAL LOW-FLUX DIALYZERS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 18: GLOBAL HEMODIALYSIS ACCESS PRODUCTS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 19: GLOBAL HEMODIALYSIS ACCESS PRODUCTS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 20: GLOBAL ARTERIOVENOUS FISTULA MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 21: GLOBAL ARTERIOVENOUS GRAFT MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 22: GLOBAL CENTRAL VENOUS CATHETERS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 23: GLOBAL BLOODLINES MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 24: GLOBAL HEMODIALYSIS CONCENTRATES/DIALYSATES MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 25: GLOBAL OTHER HEMODIALYSIS CONSUMABLES MARKET SIZE, BY REGION , 2013-2020 (USD BILLION)
  • TABLE 26: GLOBAL HEMODIALYSIS SERVICES MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 27: GLOBAL HEMODIALYSIS SERVICES MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 28: GLOBAL IN-CENTER HEMODIALYSIS SERVICES MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 29: GLOBAL HOME HEMODIALYSIS SERVICES MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 30: GLOBAL HEMODIALYSIS MARKET SIZE, BY MODALITY, 2013-2020 (USD BILLION)
  • TABLE 31: GLOBAL CONVENTIONAL LONG-TERM HEMODIALYSIS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 32: GLOBAL SHORT DAILY HEMODIALYSIS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 33: GLOBAL NOCTURNAL HEMODIALYSIS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 34: GLOBAL WATER TREATMENT SYSTEMS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 35: GLOBAL WATER TREATMENT SYSTEMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 36: GLOBAL CENTRAL WATER DISINFECTION SYSTEMS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 37: GLOBAL CENTRAL WATER DISINFECTION SYSTEMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 38: GLOBAL CENTRAL WATER CHEMICAL DISINFECTION SYSTEMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 39: GLOBAL CENTRAL WATER HEAT DISINFECTION SYSTEMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 40: GLOBAL CENTRAL WATER DISINFECTION SYSTEM ACCESSORIES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 41: GLOBAL PORTABLE WATER DISINFECTION SYSTEMS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 42: GLOBAL PORTABLE WATER DISINFECTION SYSTEMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 43: GLOBAL PORTABLE WATER CHEMICAL DISINFECTION SYSTEMS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 44: GLOBAL PORTABLE WATER HEAT DISINFECTION SYSTEMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 45: GLOBAL PORTABLE WATER DISINFECTION SYSTEM ACCESSORIES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 46: GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 47: GLOBAL PERITONEAL DIALYSIS PRODUCTS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 48: GLOBAL PERITONEAL DIALYSIS PRODUCTS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 49: GLOBAL PERITONEAL DIALYSIS CONCENTRATE/DIALYSATE MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 50: GLOBAL PERITONEAL DIALYSIS MACHINES MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 51: GLOBAL PERITONEAL DIALYSIS CATHETERS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 52: GLOBAL PERITONEAL DIALYSIS TRANSFER SETS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 53: GLOBAL OTHER DIALYSIS PRODUCTS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 54: GLOBAL PERITONEAL DIALYSIS SERVICES MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 55: GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2013-2020 (USD BILLION)
  • TABLE 56: GLOBAL CAPD MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 57: GLOBAL APD MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 58: GLOBAL DIALYSIS END-USERS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 59: GLOBAL IN-CENTER DIALYSIS END-USERS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 60: GLOBAL IN-CENTER DIALYSIS END-USERS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 61: GLOBAL HOSPITAL DIALYSIS END-USERS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 62: GLOBAL INDEPENDENT DIALYSIS CENTERS END-USERS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 63: GLOBAL HOME DIALYSIS END-USERS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 64: GLOBAL HOME DIALYSIS END-USERS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 65: GLOBAL PERITONEAL DIALYSIS END-USERS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 66: GLOBAL HOME HEMODIALYSIS END-USERS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 67: GLOBAL DIALYSIS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 68: NORTH AMERICA: DIALYSIS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
  • TABLE 69: NORTH AMERICA: DIALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 70: NORTH AMERICA: HEMODIALYSIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD BILLION)
  • TABLE 71: NORTH AMERICA: HEMODIALYSIS MARKET SIZE, BY MODALITY, 2013-2020 (USD BILLION)
  • TABLE 72: NORTH AMERICA: WATER TREATMENT SYSTEMS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 73: NORTH AMERICA: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCTS AND SERVICES, 2013-2020 (USD BILLION)
  • TABLE 74: NORTH AMERICA: PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2013-2020 (USD BILLION)
  • TABLE 75: U.S.: DIALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 76: U.S.: HEMODIALYSIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD BILLION)
  • TABLE 77: U.S.: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCTS AND SERVICES, 2013-2020 (USD BILLION)
  • TABLE 78: CANADA: DIALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 79: CANADA: HEMODIALYSIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD BILLION)
  • TABLE 80: CANADA: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCTS AND SERVICES, 2013-2020 (USD BILLION)
  • TABLE 81: EUROPE: DIALYSIS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
  • TABLE 82: EUROPE: DIALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 83: EUROPE: HEMODIALYSIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD BILLION)
  • TABLE 84: EUROPE: HEMODIALYSIS MARKET SIZE, BY MODALITY, 2013-2020 (USD BILLION)
  • TABLE 85: EUROPE: WATER TREATMENT SYSTEMS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 86: EUROPE: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCTS AND SERVICES, 2013-2020 (USD BILLION)
  • TABLE 87: EUROPE: PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2013-2020 (USD BILLION)
  • TABLE 88: GERMANY: DIALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 89: GERMANY: HEMODIALYSIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD BILLION)
  • TABLE 90: GERMANY: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCTS AND SERVICES, 2013-2020 (USD BILLION)
  • TABLE 91: FRANCE: DIALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 92: FRANCE: HEMODIALYSIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD BILLION)
  • TABLE 93: FRANCE: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCTS AND SERVICES, 2013-2020 (USD BILLION)
  • TABLE 94: U.K.: DIALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 95: U.K.: HEMODIALYSIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD BILLION)
  • TABLE 96: U.K.: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCTS AND SERVICES, 2013-2020 (USD BILLION)
  • TABLE 97: REST OF EUROPE: DIALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 98: REST OF EUROPE: HEMODIALYSIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD BILLION)
  • TABLE 99: REST OF EUROPE: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCTS AND SERVICES, 2013-2020 (USD BILLION)
  • TABLE 100: ASIA-PACIFIC: DIALYSIS MARKET SIZE, BY COUNTRY, 2013-2020 (USD BILLION)
  • TABLE 101: ASIA-PACIFIC: DIALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 102: ASIA-PACIFIC: HEMODIALYSIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD BILLION)
  • TABLE 103: ASIA-PACIFIC: HEMODIALYSIS MARKET SIZE, BY MODALITY, 2013-2020 (USD BILLION)
  • TABLE 104: ASIA-PACIFIC: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 105: ASIA-PACIFIC: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCTS AND SERVICES, 2013-2020 (USD BILLION)
  • TABLE 106: ASIA-PACIFIC: PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2013-2020 (USD BILLION)
  • TABLE 107: JAPAN: DIALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 108: JAPAN: HEMODIALYSIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD BILLION)
  • TABLE 109: JAPAN: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCTS AND SERVICES, 2013-2020 (USD BILLION)
  • TABLE 110: CHINA: DIALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 111: CHINA: HEMODIALYSIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD BILLION)
  • TABLE 112: CHINA: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCTS AND SERVICES, 2013-2020 (USD BILLION)
  • TABLE 113: INDIA: DIALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 114: INDIA: HEMODIALYSIS MARKET SIZE, BY PRODUCTS AND SERVICES, 2013-2020 (USD BILLION)
  • TABLE 115: INDIA: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCTS AND SERVICES, 2013-2020 (USD BILLION)
  • TABLE 116: ROAPAC: DIALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 117: ROAPAC: HEMODIALYSIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD BILLION)
  • TABLE 118: ROAPAC: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCTS AND SERVICES, 2013-2020 (USD BILLION)
  • TABLE 119: ROW: DIALYSIS MARKET SIZE, BY REGION, 2013-2020 (USD BILLION)
  • TABLE 120: ROW: DIALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 121: ROW: HEMODIALYSIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD BILLION)
  • TABLE 122: ROW: HEMODIALYSIS MARKET SIZE, BY MODALITY, 2013-2020 (USD BILLION)
  • TABLE 123: ROW: WATER TREATMENT SYSTEMS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 124: ROW: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCTS AND SERVICES, 2013-2020 (USD BILLION)
  • TABLE 125: ROW: PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2013-2020 (USD BILLION)
  • TABLE 126: LATIN AMERICA: DIALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 127: LATIN AMERICA: HEMODIALYSIS MARKET SIZE, BY PRODUCT & SERVICE, 2013-2020 (USD BILLION)
  • TABLE 128: LATIN AMERICA: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD BILLION)
  • TABLE 129: MIDDLE EAST: DIALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 130: MIDDLE EAST: HEMODIALYSIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD BILLION)
  • TABLE 131: MIDDLE EAST: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD BILLION)
  • TABLE 132: AFRICA: DIALYSIS MARKET SIZE, BY TYPE, 2013-2020 (USD BILLION)
  • TABLE 133: AFRICA: HEMODIALYSIS MARKET SIZE, BY PRODUCTS & SERVICES, 2013-2020 (USD BILLION)
  • TABLE 134: AFRICA: PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCTS AND SERVICES, 2013-2020 (USD BILLION)
  • TABLE 135: TOP 5 EXPANSIONS, 2012-2015
  • TABLE 136: TOP FIVE MERGERS & ACQUISITIONS, 2012-2015
  • TABLE 137: AGREEMENTS & PARTNERSHIPS, 2012-2015
  • TABLE 138: NEW PRODUCT LAUNCHES AND APPROVALS, 2012-2015
  • TABLE 139: TOP 5 OTHER DEVELOPMENTS, 2012-2015

LIST OF FIGURES

  • FIGURE 1: GLOBAL DIALYSIS MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: DATA TRIANGULATION METHODOLOGY
  • FIGURE 4: GLOBAL DIALYSIS MARKET, 2015-2020 (USD BILLION)
  • FIGURE 5: GLOBAL HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2015 VS. 2020
  • FIGURE 6: GLOBAL PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2015 VS. 2020
  • FIGURE 7: GLOBAL DIALYSIS MARKET, BY REGION, 2015 (USD BILLION)
  • FIGURE 8: EMERGING COUNTRIES OFFER HIGH-GROWTH OPPORTUNITIES TO PLAYERS IN THE DIALYSIS MARKET
  • FIGURE 9: HEMODIALYSIS SEGMENT TO DOMINATE THE GLOBAL DIALYSIS MARKET ACROSS ALL REGIONS
  • FIGURE 10: IN-CENTER DIALYSIS SEGMENT TO LEAD THE DIALYSIS MARKET ACROSS ALL REGIONS BY 2020
  • FIGURE 11: ASIA-PACIFIC TO DOMINATE THE GLOBAL DIALYSIS MARKET BY 2020
  • FIGURE 12: CAPD SEGMENT ACCOUNTS FOR THE LARGEST SHARE OF THE GLOBAL PERITONEAL DIALYSIS MARKET IN 2015
  • FIGURE 13: DIALYSIS MARKET SEGMENTATION
  • FIGURE 14: DIALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 15: RENAL PATIENT GROWTH WORLDWIDE
  • FIGURE 16: DIABETES AND HYPERTENSION ARE THE KEY CAUSES FOR ESRD AND CKD
  • FIGURE 17: TOTAL MEDICARE ESRD EXPENDITURES, BY MODALITY
  • FIGURE 18: INCREASING NUMBER OF ESRD PATIENTS DRIVE THE MARKET GROWTH
  • FIGURE 19: COMPLICATIONS ASSOCIATED WITH VARIOUS TYPES OF DIALYSIS ACCESS IN 2013
  • FIGURE 20: LIMITED REIMBURSEMENTS FOR DIALYSIS IN DEVELOPING COUNTRIES RESTRAIN THE ADOPTION OF DIALYSIS TREATMENT
  • FIGURE 21: EMERGING MARKETS REPRESENT AN UNDERSERVED PATIENT POPULATION
  • FIGURE 22: INCREASING NUMBER OF DIALYSIS CENTERS AND EMERGING MARKETS OFFER LUCRATIVE GROWTH OPPORTUNITIES
  • FIGURE 23: HIGH COST OF DIALYSIS TREATMENT - A MAJOR CHALLENGE FOR THE MARKET
  • FIGURE 24: PORTER'S FIVE FORCES ANALYSIS: DIALYSIS MARKET
  • FIGURE 25: SCORING METHODOLOGY
  • FIGURE 26: COMPARISON OF COMPETITIVE INTENSITY SCORES: BAXTER, B.BRAUN, AND FRESENIUS
  • FIGURE 27: RELATIVE POSITIONING OF COMPANIES BASED ON COMPETITIVE INTENSITY SCORE AND DIALYSIS FOCUS
  • FIGURE 28: ORGANIC AND INORGANIC GROWTH STRATEGIES: DIALYSIS PRODUCTS VS. DIALYSIS SERVICES MARKETS (2012-2015)
  • FIGURE 29: ORGANIC GROWTH STRATEGIES, BY KEY PLAYER (2012-2015)
  • FIGURE 30: INORGANIC GROWTH STRATEGIES, BY KEY PLAYER (2012-2015)
  • FIGURE 31: ORGANIC GROWTH STRATEGIES, BY KEY PLAYER (2012-2015)
  • FIGURE 32: INORGANIC GROWTH STRATEGIES, BY KEY PLAYER (2012-2015)
  • FIGURE 33: REIMBURSEMENT SCENARIO OF DIALYSIS IN 2015
  • FIGURE 34: LEVEL OF REIMBURSEMENT FOR HD AND PD ACROSS EUROPE, 2015
  • FIGURE 35: REIMBURSEMENT STRUCTURES VARY WIDELY ACROSS EUROPE
  • FIGURE 36: DIALYSIS COVERAGE IN ASIA-PACIFIC COUNTRIES, 2015
  • FIGURE 37: COMPARISON OF REIMBURSEMENT DYNAMICS FOR DIALYSIS ACROSS VARIOUS ASIAN NATIONS
  • FIGURE 38: LEVEL OF REIMBURSEMENT FOR HD AND PD ACROSS ASIA-PACIFIC COUNTRIES, 2015
  • FIGURE 39: KEY REGULATORY BODIES INVOLVED IN THE APPROVAL OF NEW DIALYSIS PRODUCTS
  • FIGURE 40: NUMBER OF DIALYSIS PATIENTS, BY REGION, 2014
  • FIGURE 41: IN-CENTER HEMODIALYSIS IS THE MOST WIDELY USED HD MODALITY FOR ESRD TREATMENT ACROSS THE GLOBE
  • FIGURE 42: CAPD WAS THE MOST WIDELY USED PD MODALITY AMONG ESRD PATIENTS IN 2013
  • FIGURE 43: HD PROCEDURES PREFERRED OVER PD AMONG RENAL PATIENTS IN MOST COUNTRIES, 2013
  • FIGURE 44: WORLDWIDE UTILIZATION OF HD AND PD, BY REGION, 2013
  • FIGURE 45: THE HEMODIALYSIS SERVICES SEGMENT IS EXPECTED TO DOMINATE THE GLOBAL DIALYSIS MARKET IN 2015
  • FIGURE 46: HEMODIALYSIS MACHINES SEGMENT IS EXPECTED TO DOMINATE THE GLOBAL HEMODIALYSIS PRODUCTS MARKET IN 2015
  • FIGURE 47: CENTER-USE HEMODIALYSIS MACHINES SEGMENT IS EXPECTED TO DOMINATE THE GLOBAL HEMODIALYSIS MACHINES MARKET IN 2015
  • FIGURE 48: DIALYZERS SEGMENT IS EXPECTED TO DOMINATE THE GLOBAL HEMODIALYSIS CONSUMABLES/SUPPLIES MARKET IN 2015
  • FIGURE 49: HOME HEMODIALYSIS SERVICES SEGMENT TO GROW AT A HIGHER CAGR IN THE GLOBAL HEMODIALYSIS SERVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 50: CONVENTIONAL HEMODIALYSIS SEGMENT IS EXPECTED TO DOMINATE THE GLOBAL HEMODIALYSIS MARKET, BY MODALITY, IN 2015
  • FIGURE 51: PORTABLE WATER DISINFECTION SYSTEMS SEGMENT TO GROW AT A HIGHER CAGR IN THE WATER TREATMENT SYSTEMS MARKET DURING THE FORECAST PERIOD
  • FIGURE 52: GLOBAL PERITONEAL DIALYSIS MARKET SHARE, BY PRODUCT AND SERVICE, 2015 VS. 2020
  • FIGURE 53: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2015 VS. 2020
  • FIGURE 54: GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2013-2020
  • FIGURE 55: APAC REGION EXPECTED TO GROW AT THE HIGHEST RATE IN THE CAPD MARKET
  • FIGURE 56: NORTH AMERICA WILL CONTINUE TO DOMINATE THE APD MARKET IN THE NEXT FIVE YEARS
  • FIGURE 57: HOME DIALYSIS SEGMENT EXPECTED TO HOLD GREATER SHARE OF THE MARKET BY 2020
  • FIGURE 58: IN-CENTER DIALYSIS MARKET SHARE, BY REGION, 2015 VS. 2020
  • FIGURE 59: APAC IS EXPECTED TO GROW AT THE HIGHEST RATE IN THE HOME DIALYSIS MARKET
  • FIGURE 60: ASIA-PACIFIC EXPECTED TO SHOW THE HIGHEST GROWTH IN THE NEXT FIVE YEARS
  • FIGURE 61: GEOGRAPHIC SNAPSHOT (2015): ASIA-PACIFIC TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 62: NORTH AMERICA MARKET SNAPSHOT
  • FIGURE 63: PATIENT GROWTH: EUROPE (2012-2013)
  • FIGURE 64: ASIA-PACIFIC MARKET SNAPSHOT
  • FIGURE 65: LEADING MARKET PLAYERS ADOPTED EXPANSION, MERGERS & ACQUISITIONS AS KEY GROWTH STRATEGIES DURING 2012-2015
  • FIGURE 66: FRESENIUS WINS THE RAT RACE IN THE DIALYSIS MARKET DUE TO ITS LEADERSHIP IN ALL DIALYSIS SEGMENTS
  • FIGURE 67: GLOBAL DIALYSIS PRODUCTS MARKET SHARE, BY KEY PLAYERS, 2014
  • FIGURE 68: TOP DIALYSIS SERVICES PROVIDERS, BY REGION, 2014
  • FIGURE 69: NUMBER OF DIALYSIS PATIENTS TREATED BY VARIOUS SERVICE PROVIDERS, BY REGION, 2014
  • FIGURE 70: GLOBAL HEMODIALYSIS PRODUCTS MARKET SHARE, BY KEY PLAYERS, 2014
  • FIGURE 71: KEY PLAYERS IN THE PERITONEAL DIALYSIS PRODUCTS MARKET
  • FIGURE 72: EXPANSION, MERGERS & ACQUISITIONS ARE THE KEY STRATEGIES
  • FIGURE 73: GEOGRAPHIC REVENUE MIX OF TOP MARKET PLAYERS
  • FIGURE 74: FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT
  • FIGURE 75: DAVITA HEALTHCARE PARTNERS INC.: COMPANY SNAPSHOT
  • FIGURE 76: BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
  • FIGURE 77: B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • FIGURE 78: NIPRO CORPORATION: COMPANY SNAPSHOT
  • FIGURE 79: ASAHI KASEI CORPORATION: COMPANY SNAPSHOT
  • FIGURE 80: NIKKISO CO., LTD: COMPANY SNAPSHOT
  • FIGURE 81: NXSTAGE MEDICAL, INC.: COMPANY SNAPSHOT
  • FIGURE 82: CANTEL MEDICAL CORP.: COMPANY SNAPSHOT
Back to Top